21 employees
Aldeyra Therapeutics develops next-generation medicines to improve the lives of patients with immune-mediated diseases.
2004
$60M
from 1 investors over 1 rounds
Aldeyra Therapeutics raised $60M on March 26, 2019
Investors: Hercules Capital, Inc.